Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-09-18 Sale |
2020-09-22 7:07 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $42.01 | $105,024 | 285,568 (Direct) |
View |
2020-09-18 Sale |
2020-09-22 7:05 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $40 | $400,000 | 274,573 (Direct) |
View |
2020-09-16 Sale |
2020-09-18 4:05 pm |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
25,000 | $37.5 | $937,500 | 138,427 (Direct) |
View |
2020-09-15 Sale |
2020-09-16 6:38 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $37.06 | $92,652 | 288,068 (Direct) |
View |
2020-09-11 Sale |
2020-09-15 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $35.02 | $70,047 | 56,334 (Direct) |
View |
2020-09-01 Sale |
2020-09-03 4:06 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $28.73 | $287,334 | 277,238 (Direct) |
View |
2020-08-03 Sale |
2020-08-05 6:55 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
7,200 | $27.26 | $196,289 | 287,116 (Direct) |
View |
2020-08-03 Sale |
2020-08-05 6:47 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
80,000 | $27.23 | $2,178,066 | 7,698,783 (Indirect Direct) |
View |
2020-08-03 Sale |
2020-08-05 6:03 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $27.37 | $273,741 | 279,780 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-09-18 Exercise |
2020-09-22 7:07 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $17 | 285,568 (Direct) |
View |
2020-09-18 Exercise |
2020-09-22 7:07 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $0 | 285,568 (Direct) |
View |
2020-09-18 Exercise |
2020-09-22 7:05 pm |
2020-05-19 2028-08-26 |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $0 | 274,573 (Direct) |
View |
2020-09-18 Exercise |
2020-09-22 7:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
5,099 | $0.28 | 274,573 (Direct) |
View |
2020-09-18 Exercise |
2020-09-22 7:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
4,901 | $0.16 | 274,573 (Direct) |
View |
2020-09-15 Exercise |
2020-09-16 6:38 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $17 | 288,068 (Direct) |
View |
2020-09-15 Exercise |
2020-09-16 6:38 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,500 | $0 | 288,068 (Direct) |
View |
2020-09-11 Exercise |
2020-09-15 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $0.34 | 56,334 (Direct) |
View |
2020-09-11 Exercise |
2020-09-15 4:05 pm |
2020-05-19 2029-07-14 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $0 | 56,334 (Direct) |
View |
2020-09-01 Exercise |
2020-09-03 4:06 pm |
2020-05-19 2028-08-26 |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $0 | 277,238 (Direct) |
View |
2020-09-01 Exercise |
2020-09-03 4:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $0.16 | 277,238 (Direct) |
View |
2020-09-01 Option Award |
2020-09-02 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,745 | $0 | 12,568 (Direct) |
View |
2020-08-16 Tax Withholding |
2020-08-18 7:09 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
5,460 | $28.53 | 459,939 (Direct) |
View |
2020-08-16 Exercise |
2020-08-18 7:09 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
12,812 | $0 | 459,939 (Direct) |
View |
2020-08-16 Exercise |
2020-08-18 7:03 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Sinha Uma Chief Scientific Officer |
468 | $0 | 23,023 (Direct) |
View |
2020-08-16 Tax Withholding |
2020-08-18 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
1,774 | $28.53 | 7,779,078 (Direct) |
View |
2020-08-16 Exercise |
2020-08-18 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
5,129 | $0 | 7,779,078 (Direct) |
View |
2020-08-16 Tax Withholding |
2020-08-18 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Stolz Brian M. Chief Operating Officer |
552 | $28.53 | 48,552 (Direct) |
View |
2020-08-16 Exercise |
2020-08-18 7:02 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Stolz Brian M. Chief Operating Officer |
1,595 | $0 | 48,552 (Direct) |
View |
2020-08-16 Tax Withholding |
2020-08-18 6:59 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
591 | $28.53 | 314,614 (Direct) |
View |
2020-08-16 Exercise |
2020-08-18 6:59 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
1,709 | $0 | 314,614 (Direct) |
View |
2020-08-16 Tax Withholding |
2020-08-18 6:58 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | YAU YI CHING Chief Accounting Officer |
138 | $28.53 | 6,978 (Direct) |
View |
2020-08-16 Exercise |
2020-08-18 6:58 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | YAU YI CHING Chief Accounting Officer |
398 | $0 | 6,978 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 6:03 pm |
2020-05-19 2028-08-26 |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $0 | 279,780 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 6:03 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $0.16 | 279,780 (Direct) |
View |